Dominant negative selection of vaccinia virus using a thymidine kinase/thymidylate kinase fusion gene and the prodrug azidothymidine

Virology

Volumn 337, Issue 2, 2005, Pages 235-241

  Holzer, Georg W ^a   Mayrhofer, Josef ^a   Gritschenberger, Werner ^a   Falkner, Falko G ^a  

^a BAXTER BIOSCIENCE   (Austria)

Author keywords

Dominant selection; Thymidine kinase; Thymidylate kinase; Vaccinia virus; Viral vectors

Indexed keywords

BACTERIAL ENZYME; THYMIDINE KINASE; ZIDOVUDINE;

ANIMAL CELL; ARTICLE; CELL LINE; DRUG INHIBITION; ESCHERICHIA COLI; FUSION GENE; GENETIC SELECTION; KNOCKOUT GENE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMALS; ANTI-HIV AGENTS; ARTIFICIAL GENE FUSION; BIOTRANSFORMATION; CELL LINE; CERCOPITHECUS AETHIOPS; ESCHERICHIA COLI; NUCLEOSIDE-PHOSPHATE KINASE; PRODRUGS; THYMIDINE KINASE; VACCINIA VIRUS; ZIDOVUDINE;

ANIMALIA; ESCHERICHIA COLI; VACCINIA; VACCINIA VIRUS;

EID: 20444428684     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.04.009     Document Type: Article

References (17)

1. R. Blasco, and B. Moss Selection of recombinant vaccinia viruses on the basis of plaque formation Gene 158 2 1995 157 162
2. B. Bouchard, V. Del Marmol, I.J. Jackson, D. Cherif, and L. Dubertret Molecular characterization of a human tyrosinase-related-protein-2 cDNA. Patterns of expression in melanocytic cells Eur. J. Biochem. 219 1-2 1994 127 134
3. D.B. Boyle, and B.E. Coupar A dominant selectable marker for the construction of recombinant poxviruses Gene 65 1 1988 123 128
4. M.W. Carroll, and B. Moss E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses Biotechniques 19 3 1995 352 356
5. S. Chakrabarti, K. Brechling, and B. Moss Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques Mol. Cell. Biol. 5 12 1985 3403 3409
6. R.C. Condit, A. Motyczka, and G. Spizz Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus Virology 128 2 1983 429 443
7. M.J. Ensinger Isolation and genetic characterization of temperature-sensitive mutants of vaccinia virus WR J. Virol. 43 3 1982 778 790
8. F.G. Falkner, and B. Moss Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors J. Virol. 62 6 1988 1849 1854
9. G.W. Holzer, and F.G. Falkner Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line J. Virol. 71 7 1997 4997 5002
10. G.W. Holzer, W. Gritschenberger, J.A. Mayrhofer, V. Wieser, F. Dorner, and F.G. Falkner Dominant host range selection of vaccinia recombinants by rescue of an essential gene Virology 249 1 1998 160 166
11. G.W. Holzer, G. Remp, G. Antoine, M. Pfleiderer, O.M. Enzersberger, W. Emsenhuber, T. Hammerle, F. Gruber, C. Urban, F.G. Falkner, and F. Dorner Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression J. Virol. 73 6 1999 4536 4542
12. M. Mackett, G.L. Smith, and B. Moss Vaccinia virus: a selectable eukaryotic cloning and expression vector Proc. Natl. Acad. Sci. U.S.A. 79 23 1982 7415 7419
13. B. Moss Poxviridae: the viruses and their replication B.N. Fields D.M. Knipe R.M. Chanock J. Melnick B. Roizman R. Shope Fields Virology 1996 Raven Press Philadelphia
14. B.T. Ober, P. Bruhl, M. Schmidt, V. Wieser, W. Gritschenberger, S. Coulibaly, H. Savidis-Dacho, M. Gerencer, and F.G. Falkner Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara J. Virol. 76 15 2002 7713 7723
15. M.A. Shneider, N.K. Rudenko, V.M. Kavsan, R. Bibilashvili, and A.A. Kraevskii The effect of 3′-azido-2′,3′-dideoxythymidine on experimental viral infections Mol. Biol. (Mosk.) 21 3 1987 837 846
16. C. Upton, D.T. Stuart, and G. McFadden Identification of a poxvirus gene encoding a uracil DNA glycosylase Proc. Natl. Acad. Sci. U.S.A. 90 10 1993 4518 4522
17. L.S. Wyatt, S.T. Shors, B.R. Murphy, and B. Moss Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model Vaccine 14 15 1996 1451 1458